About Contact Us Careers

Cell Line Development Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 713
Published Date: Dec 23, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Cell Line Development Landscape

Lonza Group Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Thermo Fisher Scientific
Corning Incorporated
General Electric Company
Sartorius AG
Selexis SA
Merck KGaA
WuXi AppTec
others

Browse Key Market Insights with Data Illustration:

Cell Line Development Market Size & Share | Growth Report 2037

In the News

Lonza Group Ltd. collaborates with Vineti to improve "Vein-to-Vein" delivery service across its manufacturing network for cell and gene therapy.
Moderna Inc. and Thermo Fisher Scientific signed a long-term agreement in February 2022 for the production of the COVID-19 vaccine and other investigational drugs based on mRNA technology.

Author Credits: Radhika Pawar

Report ID: 713
Published Date: Dec 23, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of cell line development is assessed at USD 6.5 billion.

Cell Line Development Market size was valued at USD 5.99 billion in 2024 and is expected to reach USD 20.92 billion by 2037, expanding at around 10.1% CAGR during the forecast period i.e., between 2025-2037.

North America industry is poised to dominate majority revenue share of 40% by 2037, backed by increasing investments and funds made available to manufacturing businesses and academic & research institutions to develop cell line-based end products like precision medicine and other treatments.

The major players in the market are Lonza Group Ltd., Thermo Fisher Scientific, Corning Incorporated, General Electric Company, and more.

Inquiry Before Buying Request Free Sample